CCL3 genotype and current depression increase risk of HIV-associated dementia

References

• Ances BM, Ellis RJ. Dementia and neurocognitive disorders due to HIV-1 infection. Semin Neurol. 2007;27(1):86–92.
   PubMed Web of Science ®Google Scholar
• Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 1999;13(10):1249–1253.
   PubMed Web of Science ®Google Scholar
• Valcour V, Shikuma C, Watters M, Sacktor N. Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms. Aids. 2004;18(Suppl 1):S79–S86.
   PubMed Web of Science ®Google Scholar
• Wojna V, Skolasky RL, Hechavarria R, et al. Prevalence of human immunodeficiency virus-associated cognitive impairment in a group of Hispanic women at risk for neurological impairment. J Neurovirol. 2006;12(5):356–364.
   Web of Science ®Google Scholar
• Cartier L, Hartley O, Dubois-Dauphin M, Krause KH. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases. Brain Res Brain Res Rev. 2005;48(1): 16–42.
   Google Scholar
• Levine AJ, Singer EJ, Shapshak P. The role of host genetics in the susceptibility for HIV-associated neurocognitive disorders. AIDS Behav. 2009;13(1):118–132.
   Web of Science ®Google Scholar
• Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382(6593):722–725.
   PubMed Web of Science ®Google Scholar
• Boven LA, van der Bruggen T, van Asbeck BS, Marx JJ, Nottet HS. Potential role of CCR5 polymorphism in the development of AIDS dementia complex. FEMS Immunol Med Microbiol. 1999;26(3–4): 243–247.
   Google Scholar
• Meyer L, Magierowska M, Hubert JB, et al. Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group. Aids. 1997;11(11): F73–F78.
   PubMed Web of Science ®Google Scholar
• Singh KK, Barroga CF, Hughes MD, et al; Genetic influence of CCR5, CCR2, and SDF1 variants on human immunodeficiency virus 1 (HIV-1)-related disease progression and neurological impairment, in children with symptomatic HIV-1 infection. J Infect Dis. 2003;188(10): 1461–1472.
   Web of Science ®Google Scholar
• van Rij RP, Portegies P, Hallaby T, et al. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex. J Infect Dis. 1999;180(3):854–857.
   PubMed Web of Science ®Google Scholar
• Liu H, Chao D, Nakayama EE, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A. 1999;96(8):4581–4585.
   PubMed Web of Science ®Google Scholar
• Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science. 1997;277(5328):959–965.
   Web of Science ®Google Scholar
• Singh KK, Ellis RJ, Marquie-Beck J, et al. CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults. J Neuroimmunol. 2004;157(1–2):185–192.
   Web of Science ®Google Scholar
• Michael NL, Moore JP. HIV-1 entry inhibitors: evading the issue. Nat Med. 1999;5(7):740–742.
   PubMed Web of Science ®Google Scholar
• Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science. 1998;279(5349): 389–393.
   PubMedGoogle Scholar
• Gonzalez E, Rovin BH, Sen L, et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci U S A. 2002;99(21):13795–13800.
   Web of Science ®Google Scholar
• Shrestha S, Strathdee SA, Galai N, et al. Behavioral risk exposure and host genetics of susceptibility to HIV-1 infection. J Infect Dis. 2006;193(1):16–26.
   Web of Science ®Google Scholar
• Price P, James I, Fernandez S, French MA. Alleles of the gene encoding IL-1alpha may predict control of plasma viraemia in HIV-1 patients on highly active antiretroviral therapy. Aids. 2004;18(11):1495–1501.
   Web of Science ®Google Scholar
• Quasney MW, Zhang Q, Sargent S, Mynatt M, Glass J, McArthur J. Increased frequency of the tumor necrosis factor-alpha-308. A allele in adults with human immunodeficiency virus dementia. Ann Neurol. 2001;50(2):157–162.
   Web of Science ®Google Scholar
• Pemberton LA, Stone E, Price P, van Bockxmeer F, Brew BJ. The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementia. HIV Med. 2008;9(8):677–680.
   Web of Science ®Google Scholar
• Becker JT, Lopez OL, Dew MA, Aizenstein HJ. Prevalence of cognitive disorders differs as a function of age in HIV virus infection. Aids. 2004;18(Suppl 1):S11–S18.
   PubMed Web of Science ®Google Scholar
• Cherner M, Ellis RJ, Lazzaretto D, et al. Effects of HIV-1 infection and aging on neurobehavioral functioning: preliminary findings. Aids. 2004;18(Suppl 1):S27–S34.
   PubMed Web of Science ®Google Scholar
• Cherner M, Letendre S, Heaton RK, et al. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology. 2005;64(8):1343–1347.
   PubMed Web of Science ®Google Scholar
• Tozzi V, Balestra P, Lorenzini P, et al. Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: results from an urban observational cohort. J Neurovirol. 2005;11(3):265–273.
   PubMed Web of Science ®Google Scholar
• Valcour V, Shikuma C, Shiramizu B, et al. Diabetes, insulin resistance, and dementia among HIV-1-infected patients. J Acquir Immune Defic Syndr. 2005;38(1):31–36.
   Web of Science ®Google Scholar
• Qureshi AI, Hanson DL, Jones JL, Janssen RS. Estimation of the temporal probability of human immunodeficiency virus (HIV) dementia after risk stratification for HIV-infected persons. Neurology. 1998;50(2):392–397.
   PubMed Web of Science ®Google Scholar
• Rippeth JD, Heaton RK, Carey CL, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004;10(1):1–14.
   PubMed Web of Science ®Google Scholar
• Morgello S, Gelman BB, Kozlowski PB, et al. The National NeuroAIDS Tissue Consortium: a new paradigm in brain banking with an emphasis on infectious disease. Neuropathol Appl Neurobiol. 2001;27(4):326–335.
   PubMed Web of Science ®Google Scholar
• Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26(6):759–778.
   PubMed Web of Science ®Google Scholar
• Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry. 1996;153(9): 1195–1201.
   PubMed Web of Science ®Google Scholar
• Atkinson JH, Heaton RK, Patterson TL, et al. Two-year prospective study of major depressive disorder in HIV-infected men. J Affect Disord. 2008;108(3):225–234.
   PubMed Web of Science ®Google Scholar
• Leserman J. Role of depression, stress, and trauma in HIV disease progression. Psychosom Med. 2008;70(5):539–545.
   PubMed Web of Science ®Google Scholar
• Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007;21(2):153–160.
   PubMed Web of Science ®Google Scholar
• Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27(1):24–31.
   PubMed Web of Science ®Google Scholar
• Letendre SL, Lanier ER, McCutchan JA. Cerebrospinal fluid beta chemokine concentrations in neurocognitively impaired individuals infected with human immunodeficiency virus type 1. J Infect Dis. 1999;180(2):310–319.
   Web of Science ®Google Scholar
• Li X, Margolick JB, Conover CS, et al. Interruption and discontinuation of highly active antiretroviral therapy in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr. 2005;38(3):320–328.
   PubMed Web of Science ®Google Scholar
• Gordillo V, del Amo J, Soriano V, Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS. 1999;13(13):1763–1769.
   PubMed Web of Science ®Google Scholar
• Cocchi F, DeVico AL, Garzino-Demo A, Arya SK, Gallo RC, Lusso P. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science. 1995;270(5243):1811–1815.
   PubMed Web of Science ®Google Scholar
• Moriuchi H, Moriuchi M, Combadiere C, Murphy PM, Fauci AS. CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages. Proc Natl Acad Sci U S A. 1996;93(26): 15341–15345.
   Web of Science ®Google Scholar
• Modi WS, Lautenberger J, An P, et al. Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression. Am J Hum Genet. 2006;79(1):120–128.
   Web of Science ®Google Scholar
• Gonzalez E, Dhanda R, Bamshad M, et al. Global survey of genetic variation in CCR5, RANTES, and MIP-1alpha: impact on the epidemiology of the HIV-1 pandemic. Proc Natl Acad Sci U S A. 2001;98(9):5199–5204.
   Web of Science ®Google Scholar
• Li K, Dai D, Yao L, et al. Association between the macrophage inflammatory protein-l alpha gene polymorphism and Alzheimer’s disease in the Chinese population. Neurosci Lett. 2008;433(2):125–128.
   Web of Science ®Google Scholar
• Man SM, Ma YR, Shang DS, et al. Peripheral T cells overexpress MIP-1alpha to enhance its transendothelial migration in Alzheimer’s disease. Neurobiol Aging. 2007;28(4):485–496.
   Web of Science ®Google Scholar
• Winkler C, An P, O’Brien SJ. Patterns of ethnic diversity among the genes that influence AIDS. Hum Mol Genet. 2004;13 Spec No 1: R9–R19.
   Google Scholar
• Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18): 1789–1799.
   PubMed Web of Science ®Google Scholar